DexCom Inc. closed 39.17% below its 52-week high of $142.00, which the company reached on March 26th.

DexCom, Inc. DXCM is scheduled to release fourth-quarter 2024 results on Feb. 13, after the closing bell. In the last ...

G6 continuous glucose monitor (CGM) receivers deliver glucose readings and alerts. However, certain devices may experience an ...

Amazon Health Services offers you curated choices, convenience, clarity of cost, and continuity of care on your path to get and stay healthy.

BofA Securities maintained a Buy rating on DexCom (NASDAQ:DXCM) shares, with a steady price target of $90.00. The firm's analysts suggest the current market movement presents an appealing opportunity ...

DexCom (DXCM) shares are down on Monday morning on a notification that some customers are receiving 30 days of supplies instead of 90 days amid ...

Eversense 365, the world’s first 365-day CGM system, is the only CGM offering a year-long wear time. Market-leading, ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...